190 related articles for article (PubMed ID: 31977847)
1. High ubiquitin conjugating enzyme E2 T mRNA expression and its prognostic significance in lung adenocarcinoma: A study based on the TCGA database.
Wu ZH; Zhang YJ; Sun HY
Medicine (Baltimore); 2020 Jan; 99(4):e18543. PubMed ID: 31977847
[TBL] [Abstract][Full Text] [Related]
2. High GJB2 mRNA expression and its prognostic significance in lung adenocarcinoma: a study based on the TCGA database.
Tang Y; Zhang YJ; Wu ZH
Medicine (Baltimore); 2020 Apr; 99(14):e19054. PubMed ID: 32243356
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
Cao K; Ling X; Jiang X; Ma J; Zhu J
Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
[TBL] [Abstract][Full Text] [Related]
4. UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.
Zhu J; Ao H; Liu M; Cao K; Ma J
J Transl Med; 2021 Aug; 19(1):374. PubMed ID: 34461934
[TBL] [Abstract][Full Text] [Related]
5. UBE2V2 Positively Correlates With PD-L1 Expression and Confers Poor Patient Survival in Lung Adenocarcinoma.
Hua ZD; Liu XB; Sheng JH; Li C; Li P; Cai XQ; Han ZQ
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):585-591. PubMed ID: 33734107
[TBL] [Abstract][Full Text] [Related]
6. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R
Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689
[TBL] [Abstract][Full Text] [Related]
7. FOXA1/UBE2T Inhibits CD8
Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).
Li Y; Yang X; Lu D
Bioengineered; 2022 May; 13(5):11867-11880. PubMed ID: 35543375
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung Adenocarcinoma.
Xu F; Xiong N; Yuan Y; Liu J
J Oncol; 2022; 2022():5244820. PubMed ID: 36245987
[TBL] [Abstract][Full Text] [Related]
11. Expression of UBE2C in lung adenocarcinoma based on database analysis and its clinical significance.
Liu Y; Huang F; Chen H; Peng Q; Zhao C; Miao L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Sept 28; 45(9):1044-1052. PubMed ID: 33051417
[TBL] [Abstract][Full Text] [Related]
12. UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma.
Wang X; Liu Y; Leng X; Cao K; Sun W; Zhu J; Ma J
Pathol Oncol Res; 2021; 27():632531. PubMed ID: 34257599
[No Abstract] [Full Text] [Related]
13. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
14. UBE2T mediates SORBS3 ubiquitination to enhance IL-6/STAT3 signaling and promote lung adenocarcinoma progression.
Pu J; Wang B; Zhang D; Wang K; Yang Z; Zhu P; Song Q
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23743. PubMed ID: 38816989
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
[TBL] [Abstract][Full Text] [Related]
16. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J
Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154
[TBL] [Abstract][Full Text] [Related]
17. High Expression of
Deng H; Huang Y; Wang L; Chen M
Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
[TBL] [Abstract][Full Text] [Related]
18. Integrative bioinformatics analysis the clinical value of KMT5A in different subtypes of lung cancer.
Liu S; Tian W; Li B
Comput Biol Chem; 2022 Feb; 96():107603. PubMed ID: 34894606
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
20. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma.
Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P
Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]